Heterogeneity in D׳Amico classification–based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility-Reference-Cited by-同舟云学术

Heterogeneity in D׳Amico classification–based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility

Published:2015-07 Issue:7 Volume:33 Page:329.e13-329.e19
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Schiffmann Jonas,Wenzel Philipp,Salomon Georg,Budäus Lars,Schlomm Thorsten,Minner Sarah,Wittmer Corinna,Kraft Stefan,Krech Till,Steurer Stefan,Sauter Guido,Beyer Burkhard,Boehm Katharina,Tilki Derya,Michl Uwe,Huland Hartwig,Graefen Markus,Karakiewicz Pierre I.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis;Bastian;Cancer,2004

2. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer;Klotz;J Clin Oncol,2010

3. Active surveillance for the management of prostate cancer in a contemporary cohort;Dall׳Era;Cancer,2008

4. Prospective validation of active surveillance in prostate cancer: the PRIAS study;van den Bergh;Eur Urol,2007

5. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment;Soloway;Eur Urol,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups;The Prostate;2024-05-27

2. Determination of TMPRSS2‐ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis;Cell Biology International;2023-02-05

3. Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis;Current Oncology;2022-12-22

4. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis;World Journal of Urology;2022-12-19

5. Prognostic Impact and Clinical Implications of Unfavorable Upgrading in Low-Risk Prostate Cancer after Robot-Assisted Radical Prostatectomy: Results of a Single Tertiary Referral Center;Cancers;2022-12-09